Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Holvoet

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Thrombosis and Haemostasis|November 1, 1996
Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failureP Holvoet, J Donck, M Landeloos, et al.
The Journal of Biological Chemistry|October 15, 1991
Characterization of a chimeric plasminogen activator consisting of a single-chain Fv fragment derived from a fibrin fragment D-dimer-specific antibody and a truncated single-chain urokinaseP Holvoet, Y Laroche, H R Lijnen, et al.
British Journal of Pharmacology|December 7, 2007
Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosisP-J Guns, T Van Assche, W Verreth, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 14, 2000
Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesisB De Geest, D Stengel, M Landeloos, et al.
Thrombosis and Haemostasis|July 4, 2001
Adipose tissue expression of gelatinases in mouse models of obesityH R Lijnen, E Maquoi, P Holvoet, et al.
Biochemistry|October 17, 1995
Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutantsP Holvoet, Z Zhao, B Vanloo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
Circulating oxidized LDL is a useful marker for identifying patients with coronary artery diseaseP Holvoet, A Mertens, P Verhamme, et al.
European Journal of Biochemistry|December 15, 1992
Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinaseP Holvoet, Y Laroche, H R Lijnen, et al.
Thrombosis and Haemostasis|August 3, 1992
Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinaseM Dewerchin, A M Vandamme, P Holvoet, et al.
Thrombosis and Haemostasis|February 3, 1987
Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosisI Juhan-Vague, J Valadier, M C Alessi, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Thrombosis and Haemostasis|November 1, 1996
Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failureP Holvoet, J Donck, M Landeloos, et al.
The Journal of Biological Chemistry|October 15, 1991
Characterization of a chimeric plasminogen activator consisting of a single-chain Fv fragment derived from a fibrin fragment D-dimer-specific antibody and a truncated single-chain urokinaseP Holvoet, Y Laroche, H R Lijnen, et al.
British Journal of Pharmacology|December 7, 2007
Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosisP-J Guns, T Van Assche, W Verreth, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 14, 2000
Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesisB De Geest, D Stengel, M Landeloos, et al.
Thrombosis and Haemostasis|July 4, 2001
Adipose tissue expression of gelatinases in mouse models of obesityH R Lijnen, E Maquoi, P Holvoet, et al.
Biochemistry|October 17, 1995
Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutantsP Holvoet, Z Zhao, B Vanloo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
Circulating oxidized LDL is a useful marker for identifying patients with coronary artery diseaseP Holvoet, A Mertens, P Verhamme, et al.
European Journal of Biochemistry|December 15, 1992
Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinaseP Holvoet, Y Laroche, H R Lijnen, et al.
Thrombosis and Haemostasis|August 3, 1992
Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinaseM Dewerchin, A M Vandamme, P Holvoet, et al.
Thrombosis and Haemostasis|February 3, 1987
Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosisI Juhan-Vague, J Valadier, M C Alessi, et al.
Pageof 8